Prospecto: information for the user
risperidone
Read this prospect carefully before starting to use this medicine, because it contains important information for you.
Risperdal Consta belongs to a group of medicines called “antipsychotics”.
Risperdal Consta is used in the maintenance treatment of schizophrenia, which is characterized by seeing, hearing or feeling things that are not present, believing in something that is not true or unusually feeling distrust or confusion.
Risperdal Consta is intended for patients who are currently being treated with oral antipsychotics (e.g., tablets, capsules).
Risperdal Consta may help reduce the symptoms of your illness and prevent them from returning.
Warnings and precautions
Consult your doctor or pharmacist before using Risperdal Consta if:
If you are unsure whether the information above affects you, talk to your doctor or pharmacist before using Risperdal or Risperdal Consta.
Because in very rare cases, a dangerously low number of a type of white blood cell necessary to fight infections in the blood has been observed in patients treated with Risperdal Consta, your doctor may check your white blood cell count.
Rarely, allergic reactions occur after receiving injections of Risperdal Consta, even if you have previously tolerated oral risperidone. Seek medical attention immediately if you experience hives, throat swelling, itching, or breathing difficulties, as these may be symptoms of a severe allergic reaction.
Risperdal Consta may cause you to gain weight. Significant weight gain can negatively affect your health. Your doctor will regularly monitor your weight.
Because diabetes mellitus or worsening of pre-existing diabetes mellitus has been seen in patients taking Risperdal, your doctor should check for signs of elevated blood sugar. In patients with pre-existing diabetes mellitus, blood sugar should be monitored regularly.
Risperdal Consta frequently increases levels of a hormone called "prolactin." This can cause adverse effects such as menstrual disorders or fertility problems in women or breast enlargement in men (see Possible Adverse Effects). If these adverse effects occur, it is recommended that blood prolactin levels be evaluated.
During eye surgery for cataracts, the pupil (the black circle in the middle of the eye) may not dilate as needed. Additionally, the iris (the colored part of the eye) may become flaccid during surgery and this can cause eye damage. If you are planning eye surgery, be sure to inform your ophthalmologist that you are using this medication.
Patients with advanced age and dementia
Risperdal Consta is not used in people with advanced age and dementia.
If you or your caregiver notice a sudden change in your mental state or the sudden appearance of weakness or numbness in the face, arms, or legs, especially on one side, or confused speech, even for a short time, seek medical treatment immediately. This may be a sign of a stroke.
Patients with kidney or liver problems
Although oral risperidone has been studied, Risperdal Consta has not been studied in patients with kidney or liver problems. Risperdal Consta should be administered with caution in this group of patients.
Use of Risperdal Consta with other medications
Inform your doctor or pharmacist if you are using or have used recently or may need to use any other medication.
It is especially important to talk to your doctor or pharmacist if you take any of the following
The following medications may reduce the effect of risperidone
If you start or stop taking these medications, you may need a different dose of risperidone.
The following medications may increase the effect of risperidone
If you start or stop taking these medications, you may need a different dose of risperidone.
If you are unsure whether the information above affects you, talk to your doctor or pharmacist before using Risperdal Consta.
Use of Risperdal Consta with food, drinks, and alcohol
You should avoid consuming alcohol while using Risperdal Consta.
Pregnancy, breastfeeding, and fertility
Driving and using machines
Dizziness, fatigue, and vision problems have been observed during treatment with Risperdal Consta. Do not drive or use tools or machinery without consulting your doctor first.
Risperdal Consta contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per dose; that is, it is essentially "sodium-free."
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Risperdal Consta is administered via intramuscular injection in the arm or buttock every two weeks by a healthcare professional. The injections should be alternated between the left and right sides and should not be administered intravenously.
The recommended dose is as follows:
Adults
Initial dose
If your daily dose of oral risperidone (e.g., tablets) was 4 milligrams or less during the past two weeks, your initial dose should be 25 milligrams of Risperdal Consta.
If your daily dose of oral risperidone (e.g., tablets) was more than 4 milligrams during the past two weeks, you may be given a dose of 37.5 milligrams of Risperdal Consta as the initial dose.
If you are currently being treated with another oral antipsychotic that is not risperidone, your initial dose of Risperdal Consta will depend on your current treatment. Your doctor will choose Risperdal Consta 25 mg or 37.5 mg.
Your doctor will decide if this dose of Risperdal Consta is suitable for you.
Maintenance dose
If you use more Risperdal Consta than you should
It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you interrupt treatment with Risperdal Consta
You will lose the effects of this medication. Do not stop using this medication unless your doctor has told you to, as you may experience symptoms again. Make sure to receive your injections every two weeks. If you cannot attend your appointments, contact your doctor immediately to schedule another appointment when you can.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Use in children and adolescents
Children and adolescents under 18 years old should not receive Risperdal Consta.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Inform your doctor immediately if you experience any of the following rare side effects (may affect up to 1 in 100 patients):
Inform your doctor immediately if you experience any of the following rare side effects (may affect up to 1 in 1,000 patients):
Other side effects may also occur:
Very common side effects (may affect more than 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Rare side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Unknown frequency: cannot be estimated from available data
The following side effect has occurred with the use of another medicine called paliperidone, which is very similar to risperidone, so it is also expected to occur with Risperdal Consta: Fast heart rate when standing up.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging. The expiration date is the last day of the month indicated.
Store in refrigerator (between 2°C and 8°C). If refrigeration is not available, the packaging can be stored below 25°C for a maximum of 7 days before administration. Administer within 6 hours after reconstitution (if stored at 25°C or less).
Store in the original packaging to protect it from light.
Medications should not be disposed of through drains or trash. Dispose of packaging and medications you no longer need at the SIGRE point of your pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Risperdal Consta
The active ingredient is risperidone.
Each Risperdal Consta powder and solvent for prolonged-release suspension for injection contains 50 milligrams of risperidone.
The other components are:
Powder
poly-(d,l-lactide-co-glycolide).
Solvent (solution):
Polysorbate 20, Sodium Carmellose, Dihydrated Disodium Phosphate, Anhydrous Citric Acid, Sodium Chloride, Sodium Hydroxide, Injection Water.
Appearance of Risperdal Consta and contents of the package
Risperdal Consta is available in packs containing 1 to 5 grouped containers.
Only some sizes of containers may be commercially available.
Marketing authorization holder and manufacturer responsible
Marketing authorization holder
JANSSEN-CILAG, S.A.
Paseo de Las Doce Estrellas, 5-7
28042 Madrid, Spain
+34 917228100
+34 917228101
Manufacturer responsible
Janssen Pharmaceutica, N.V
Turnhoutseweg, 30
B-2340, Beerse
Belgium
This medicine has been authorized in the Member States of the EEA with the following names:
Austria:RISPERDALCONSTA
Belgium:RISPERDALCONSTA
Cyprus:RISPERDALCONSTA
Czech Republic:RISPERDAL CONSTA
Denmark:RISPERDALCONSTA
Estonia:RISPOLEPTCONSTA
Finland:RISPERDALCONSTA
France:RISPERDAL CONSTA LP
Germany:RISPERDAL CONSTA 25mg, 37.5mg, 50mg
Greece:RISPERDALCONSTA
Hungary:RISPERDAL CONSTA
Iceland:RISPERDALCONSTA
Ireland:RISPERDALCONSTA
Italy:RISPERDAL
Lithuania:RISPOLEPTCONSTA
Latvia:RISPOLEPTCONSTA
Liechtenstein:RISPERDALCONSTA
Luxembourg:RISPERDALCONSTA
Malta:RISPERDALCONSTA
Netherlands:RISPERDALCONSTA
Norway:RISPERDAL CONSTA
Poland:RISPOLEPTCONSTA
Portugal:RISPERDAL CONSTA
Romania:RISPOLEPT CONSTA
Slovakia:RISPERDALCONSTA
Slovenia:RISPERDAL CONSTA
Spain:RISPERDAL CONSTA
Sweden:RISPERDALCONSTA
United Kingdom:RISPERDALCONSTA
This leaflet was last revised in:April 2021.
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es
IMPORTANT INFORMATION FOR THE HEALTHCARE PROFESSIONAL
Important information
RISPERDAL CONSTA requires careful attention at every step of the “Instructions for Use” to help ensure a successful administration.
Use of the provided components
The components of the package are specifically designed for use with RISPERDAL CONSTA. RISPERDAL CONSTA must be reconstituted only with the solvent provided in the package.
Do not substitute any of the components of the package.
Do not store the suspension after reconstitution.
Administer the dose as soon as possible after reconstitution to avoid sedimentation.
Adequate dose
The entire contents of the vial must be administered to ensure that the adequate dose of RISPERDAL CONSTA is administered.
Do not reuse.The medical devices require materials with specific characteristics to function properly. These characteristics have been verified for single use. Any attempt to reprocess the device for subsequent reuse may negatively affect the integrity of the device or lead to deterioration of its function.
Components of the package
Step 1 | Assemble the components | ||
Remove the dose container | Connect the vial adapter to the vial | ||
Wait 30 minutes Remove the dose container from the refrigerator and allow it to reach room temperature for at least30 minutesbefore reconstitution. Do not heatin any other way. | Remove the vial cap Remove the colored cap from the vial. Clean the top of the gray stopper with analcohol swab Do not removethe gray rubber stopper. | Prepare the vial adapter Hold the sterile blister as shown. Remove the paper support. Do not removethe vial adapter from the blister. Do not touchthe tip of the needle at any time. This may lead to contamination. | Couple the vial adapter to the vial Place the vial on a hard, flat surface and hold it by the base. Center the vial adapter over the gray rubber stopper. Press the vial adapter straight down until it securely fits into the vial. Do notplace the vial adapter at an angle, as it may lose solvent during transfer to the vial. |
Couple the preloaded syringe to the vial adapter
Remove the sterile blister Hold the vial vertically to prevent losses. Hold the base of the vial and pull the sterile blister to remove it. Do not agitate. Do not touchthe exposed luer (cone) of the vial adapter. This may lead to contamination. | Use the correct gripping area Hold by the white ring at the tip of the syringe. Do nothold the syringe by the glass during assembly. | Remove the capsule Hold the white ring and break the white capsule. Do notrotate or cut the white capsule. Do not touchthe tip of the syringe. This may lead to contamination. The broken capsule can be discarded. | Couple the syringe to the vial adapter Hold the vial adapter by the rim to keep it fixed. Hold the syringe by the white ringand then insert the tip into the opening of the luer (cone) of the vial adapter. Do nothold the syringe by the glass cylinder. This may cause the white ring to loosen or come off. Couple the syringe to the vial adapter witha firm rotation in a clockwise directionuntil it is securely attached. Do notpress too hard. Pressing too hard may cause the tip of the syringe to break. | ||
Step 2 | Reconstitute the microspheres | ||||
Inject solvent Inject the entire amount of solvent from the syringe into the vial. | Suspend the microspheres in the solvent Continue pressing down on the plunger with your thumb,shakeenergetically,as shown, for at least 10 seconds. Check the suspension. When properly mixed, the suspension will have a uniform, dense, and milky appearance. The microspheres will be visible in the liquid. Immediately proceed to the next step to avoid sedimentation. | Transfer the suspension to the syringe Invert the vial completely. Pull the plunger rod down slowly to transfer the entire contents of the vial to the syringe. | Remove the vial adapter Hold the syringe by the white ring and disengage it from the vial adapter. Cut the label from the vial at the perforated area. Place the detached label on the syringe to identify it. Properly dispose of both the vial and the vial adapter (see section 5 of this leaflet). |
Step 3 | Place the needle | |||
Choose the correct needle Choose the needle according to the injection site (gluteal or deltoid). | Place the needle Open the blister pack by the partially peeled area and use it to pick up the base of the needle, as shown. Do not touchthe exposed opening of the luer (cone) of the needle. This may lead to contamination. | Resuspend the microspheres Remove the blister pack completely. Just before injection, shake the syringe again energetically, in case sedimentation has occurred. | ||
Step 4 | Inject the dose | |||
Remove the transparent needle shield Moving the safety device of the needle towards the syringe, as shown. Then, hold the white ring of the syringe and carefully remove the transparent needle shield. | Remove air bubbles Hold the syringe upwards and gently tap to bring the air bubbles to the top. | Inject Inject the entire contents of the syringe intramuscularly (IM) into the gluteal or deltoid muscle of the patient. The gluteal injection should be made in the upper outer quadrant of the gluteus. | Protect the needle in the safety device Usingone hand, place the safety device of the needle at a 45-degree angle on a flat, hard surface. Press down firmly and quickly until the needle is completely inside the safety device. To avoid a needlestick injury: Do notuse two hands. Do notmanipulate or deliberately disengage the safety device of the needle. Do notattempt to straighten the needle or couple the safety device if the needle is bent or damaged. | Properly dispose of the needles Check that the safety device of the needle is securely attached. Dispose of it in a used needle container. |
The average price of Risperdal consta 50 mg polvo y disolvente para suspension de liberacion prolongada para inyeccion intramuscular in July, 2025 is around 138.28 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.